Expression of CD28, Fas, PD1, and CTLA4 molecules on cellular immune response in the blood peripheral of patients with locally advanced triplenegative breast cancer

被引:0
|
作者
Salgado, Marcelo
Soares, Fernando
Viana, Denise
Salgado, Amanda
Vasconcelos, Carolina
Anunciacao, Carlos Eduardo
Salgado, Eduardo
Torres, Leuridan
机构
关键词
D O I
10.1158/1538-7445.SABCS23-PO3-25-06
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO3-25-06
引用
收藏
页数:2
相关论文
共 31 条
  • [21] Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
    Saleh, Reem
    Toor, Salman M.
    Khalaf, Sarah
    Elkord, Eyad
    VACCINES, 2019, 7 (04)
  • [22] ERCC1 RNA Expression in Peripheral Blood Predicts Minor Histopathological Response to Neoadjuvant Radio-chemotherapy in Patients with Locally Advanced Cancer of the Esophagus
    Brabender, Jan
    Vallboehmer, Daniel
    Grimminger, Peter
    Ling, Frederike
    Lurje, Georg
    Bollschweiler, Elfriede
    Schneider, Paul M.
    Hoelscher, Arnulf H.
    Metzger, Ralf
    Hoffmann, Andreas C.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (11) : 1815 - 1821
  • [23] ERCC1 RNA Expression in Peripheral Blood Predicts Minor Histopathological Response to Neoadjuvant Radio-chemotherapy in Patients with Locally Advanced Cancer of the Esophagus
    Jan Brabender
    Daniel Vallböhmer
    Peter Grimminger
    Andreas C. Hoffmann
    Frederike Ling
    Georg Lurje
    Elfriede Bollschweiler
    Paul M. Schneider
    Arnulf H. Hölscher
    Ralf Metzger
    Journal of Gastrointestinal Surgery, 2008, 12 : 1815 - 1821
  • [24] Effect of Low vs Standard Dosage of Anti-Thymocyte Globulin Induction Therapy on the Co-Inducible Molecules (Cd28, CTLA-4, ICOS, PD-1) Expression Pattern in T Regulatory Cell
    Queipo, G.
    Hernandez-Mendoza, A.
    Estrada-Matus, M.
    Fonseca-Sanchez, M.
    Oviedo, F.
    Garcia-Cobarruvias, L.
    Prieto Chavez, J.
    Pizarro, L.
    Morales-Buenrostro, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 622 - 622
  • [25] Peripheral CD45RO, PD1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab/5FU/irinotecan (B-FOLFIRI)
    Formica, V.
    Cereda, V.
    Di Bari, M. G.
    Grenga, I.
    Tesauro, M.
    Palmirotta, R.
    Ferroni, R.
    Guadagni, F.
    Roselli, M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S570 - S570
  • [26] A novel peripheral CD4+T cell immune network associated with response to PD-1 inhibitor in early-stage triple negative breast cancer
    Wang, Zehao
    Shao, Zhibo
    Xiu, Bingqiu
    Wu, Jiong
    CANCER RESEARCH, 2024, 84 (09)
  • [27] Prognostic significances of PD-L1-and CTLA-4-positive T cells and positive correlations of immunosuppressive marker expression between cancer tissue and peripheral blood in patients with gastric cancer
    Lee, Kun Hee
    Kim, So Jung
    Woo, Jin Seok
    Lee, Seung Yoon
    Jhun, Jooyeon
    Moon, Jeonghyeon
    Jung, Yoon Ju
    Cho, Mi-La
    Song, Kyo Young
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [28] Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to neoadjuvant chemotherapy (NAD-CT) in locally advanced Gastric Cancer (LAGC)
    Martini, M.
    Zurlo, I. V.
    Strippoli, A.
    Cocomazzi, A.
    Tortora, G.
    Bria, E.
    Basso, M.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S15 - S15
  • [29] Peripheral CD4+ T cell Signatures in Predicting Response to Anti-PD-1 Monotherapy for Chinese Advanced Non-Small Cell Lung Cancer Patients
    Wang, Y.
    Xia, L.
    Yang, Y.
    Li, H.
    Ji, P.
    Chen, Y.
    Lu, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S408 - S408
  • [30] Metastatic breast cancer is associated with increased levels of soluble forms of TIM-3 and LAG-3 and decreased levels of soluble forms of GITR, GITR-L, CD27, CD28, CD40, CD86, ICOS, PD-L1, CTLA-4 and BTLA
    Smit, T.
    Rapoport, B. L.
    Steel, H.
    Heyman, L.
    Benn, C-A.
    Anderson, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S387 - S387